|
VOLUME 32: NO. 3 MARCH 2005
Editorials
Subgroups Within "Nonspecific" Low Back Pain

G. Waddell ......... 395
Thrombosis and Inflammation: A Question in
Need of an Answer

R. Bobba, C. Landolt-Marticorena, P.R. Fortin ......... 397
Phospholipase A2: Quo Vadis?

W. Pruzanski ......... 400
Study Eligibility Criteria: The Perils of
Feasibility Based Decision Making

A.M. Davis ......... 403
Articles
Osteopontin Gene Polymorphisms in Spanish
Patients with RA

E. Urcelay, A. Martínez, A. Mas-Fontao, et al ......... 405
Overexpression of Osteopontin in Rheumatoid Synovial Mononuclear Cells Is Associated with Joint Inflammation, Not with Genetic Polymorphism

G. Xu, W. Sun, D. He, et al ......... 410
A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial of LY333013, a Selective Inhibitor of
Group II Secretory PLA2, in the Treatment of RA

J.D. Bradley, A.A. Dmitrienko, A.J. Kivitz, et al ......... 417
Detection of the p53 Regulator Murine Double-Minute Protein 2 in RA

E. Taranto, J.R. Xue, D. Lacey, et al .........424
Prediction of Mortality in RA Based on Disease
Activity Markers

C. Book, T. Saxne, L.T.H. Jacobsson ......... 430
Traditional and Nontraditional Cardiovascular Risk Factors Are Associated with Atherosclerosis in RA

P.H. Dessein, B.J. Joffe, M.G. Veller, et al ......... 435
Valuing a Hypothetical Cure for RA Using the Contingent Valuation Methodology: The Patient Perspective

B. Fautrel, A.E. Clarke, F. Guillemin, et al ......... 443
Studies of Serum CRP in SLE
 R.C. Williams Jr,
M.E. Harmon, R. Burlingame, T.W. Du Clos ......... 454
Inflammation in Patients with Lupus Anticoagulant and Implications for Thrombosis

T. Sailer, R. Vormittag,
I. Pabinger, et al ......... 462
Antiinflammatory Effect of A3 Adenosine Receptor Agonists in Murine Autoimmune Arthritis Models

E. Baharav, S. Bar-Yehuda, L. Madi, et al ......... 469
The Cytoplasmic Dot Staining Pattern Is Detected
in a Subgroup of Patients with Primary Biliary
Cirrhosis

D.B. Bloch, J.H. Yu, W-H. Yang, et al ......... 477
CNS Involvement in Hepatitis C Virus
Cryoglobulinemia Vasculitis: A Multicenter
Case-Control Study Using MRI and
Neuropsychological Tests

M. Casato, D. Saadoun, A. Marchetti, et al ......... 484
Absence of Cyclic Citrullinated Peptide Antibody in Nonarthritic Patients with Chronic Hepatitis C
Infection

>D. Lienesch, R. Morris, A. Metzger,
P. Debuys, K. Sherman ......... 489
Patients with SSc Have Unique and Persistent Alterations in Gastric Myoelectrical Activity with Acupressure to Neiguan Point PC6

D.E. Wollaston,
X. Xu, O. Tokumaru, J.D.Z. Chen, T.A. McNearney ......... 494
Ischemic Heart Disease in Patients from Northwest Spain with Biopsy Proven GCA. A Population Based Study

M.A. Gonzalez-Gay, G. Rubiera, A. Piñeiro, et al ......... 502
MCP-1 Gene Haplotype Association in Biopsy Proven GCA

M.M. Amoli, F. Salway, E. Zeggini, W.E.R. Ollier,
M.A. Gonzalez-Gay ......... 507
Antibodies to Cyclic Citrullinated Peptides in PsA

L. Bogliolo, C. Alpini, R. Caporali, C.A. Scirè,
R. Moratti, C. Montecucco ......... 511
Impact of Functional Impairment in AS: Impairment, Activity Limitation, and Participation Restrictions

H. Dagfinrud, I. Kjeken, P. Mowinckel, K.B. Hagen,
T.K. Kvien ......... 516
Reactive Joint Symptoms Following an Outbreak
of Salmonella typhimurium Phage Type 135a

A.T.Y. Lee, R.G. Hall, K.D. Pile ......... 524
Epidemiological Differences Between Back Pain of Sudden and Gradual Onset

J. Smedley, H. Inskip,
P. Buckle, C. Cooper, D. Coggon ......... 528
Patient Preference in a Crossover Clinical Trial of Patients with OA of the Knee or Hip: Face Validity of Self-Report Questionnaire Ratings

T. Pincus, X. Wang, C. Chung, T. Sokka, G.G. Koch ......... 533
What WOMAC Pain Score Should Make a Patient Eligible for a Trial in Knee OA?

J. Goggins, K. Baker, D. Felson ......... 540
Self-Management in OA of Hip or Knee:
A Randomized Clinical Trial in a Primary
Healthcare Setting

P.H.T.G. Heuts, R. de Bie, M. Drietelaar, et al ......... 543
Fracture Prevalence and Treatment with Bone-Sparing Agents: Are There Urban-Rural Differences?
A Population Based Study in Ontario, Canada

S.M. Cadarette, S.B. Jaglal, G.A. Hawker ......... 550
Pediatric Rheumatology
Evaluation of Revised ILAR Classification Criteria
for JIA in Spanish Children (Edmonton 2001)

R. Merino, J. De Inocencio, J. García-Consuegra ......... 559
Case Reports
Two Cases of ANA Negative Lupus Showing
Increased Proportion of B Cells Lacking RP105

S. Koarada, M. Ide, Y. Haruta, et al ......... 562
Multicentric Reticulohistiocytosis Responding
to TNF-a Inhibition in a Renal Transplant Patient

S.E. Shannon, H.R. Schumacher, S. Self,
A.N. Brown ......... 565
Correspondence
Trial of Tramadol/Acetaminophen Tablets for
OA Pain in Subjects Receiving a COX-2 NSAID
M.H. Ellman, J. Curran ......... 568
Reply R. Emkey ......... 568
Book Review
Low Back and Neck Pain: Comprehensive Diagnosis and Management ......... 569
Correction
Chronic Back Pain: Searching for Causes and Cures
J.H. Atkinson ......... 569
Meetings in Rheumatology
|